Guidehouse Teams Up with HIMSS to Advance Digital Health Transformation
MCLEAN, Va., Feb. 10, 2025 /PRNewswire/ -- Guidehouse, a global consultancy providing advisory, digital, and managed services to the commercial and public sectors, has teamed up with the Healthcare Information and Management Systems Society (HIMSS), a trusted global authority on healthcare innovation, to advance digital health transformation. As a new member of the HIMSS Digital Health Consulting Partner (DHCP) program, Guidehouse will use HIMSS digital maturity models to assess healthcare organizations' technology capabilities, implement tailored strategies and solutions, and work with organizations to help them reach a more advanced state of digital health adoption.
HIMSS digital maturity models have been used for more than a decade in over 7,000 healthcare facilities across the U.S. As a part of this initiative, Guidehouse will use three HIMSS models:
HIMSS Analytics Maturity Assessment Model (AMAM): This model, with a newly added AI governance and deployment component, supports advanced analytics literacy, robust data governance, and transparency in patient data management, while enabling organizations to scale AI-driven insights for population health improvements.
HIMSS Community Care Outcomes Maturity Model (C-COMM): Designed for non-acute care organizations, this model emphasizes strategic access to care by focusing on improving health outcomes for specific population segments through proactive interventions and prevention strategies. Focused on value-based care, the C-COMM model fosters innovation and supports comprehensive digital health transformation in community-based care settings, ensuring more efficient, patient-centered delivery.
HIMSS Electronic Medical Record (EMR) Adoption Model (EMRAM): HIMSS' flagship model evaluates the impact of EMR adoption on system performance and patient outcomes. It promotes operational efficiency, patient safety, care quality, and enhanced engagement by driving the optimization of EMR usage across organizations.
'This engagement between Guidehouse and HIMSS is a pivotal step in equipping healthcare organizations with the tools and insights they need to achieve sustainable digital transformation,' said Tim Kinney, Guidehouse partner and Payer/Provider practice leader. 'These models will help our clients assess their digital maturity, pinpoint opportunities for growth, and deliver measurable value to the communities they serve.'
'HIMSS' maturity models offer a structured roadmap to help organizations bridge the gap between technology and care delivery,' added Reid Oakes, Chief Products Officer, HIMSS. 'By working with Guidehouse, we are scaling the impact of these tools to help healthcare organizations achieve their transformation goals, improve outcomes, and enhance system-wide efficiency.'
A global consultancy providing advisory, digital, and managed services, Guidehouse's Health segment serves providers, government agencies, life sciences companies, payers, and other healthcare organizations. Backed by proven success in modernizing and innovating healthcare services, finances, and operations, the firm delivers a comprehensive approach to solving interrelated industry challenges. A 22-time Best in KLAS® award winner, Guidehouse received three awards for its strategy, revenue cycle, and outsourced coding services in 2025.
With over six decades of leadership in healthcare innovation, HIMSS connects a global network of healthcare professionals, technology innovators, and industry leaders dedicated to advancing the health ecosystem through information and technology. The organization is renowned for its pioneering frameworks and trusted resources that help healthcare organizations address critical challenges and drive sustainable transformation.
About Guidehouse
Guidehouse is a global consultancy providing advisory, digital, and managed services to the commercial and public sectors. Guidehouse is purpose-built to serve the national security, financial services, healthcare, energy, and infrastructure industries. Disrupting legacy consulting delivery models with its agility, capabilities, and scale, the firm delivers technology-enabled and focused solutions that position clients for innovation, resilience, and growth. With high-quality standards and a relentless pursuit of client success, Guidehouse's more than 18,000 employees collaborate with leaders to outwit complexity and achieve transformational changes that meaningfully shape the future. guidehouse.com
About the Healthcare Information and Management Systems Society (HIMSS)
The HIMSS Vision is to realize the full health potential of every human, everywhere. The HIMSS Mission is to reform the global health ecosystem through the power of information and technology. With a professional society of more than 125,000 individuals, 430 provider organizations, and 1,000 health services and non-profits organizations, HIMSS offers a unique depth and breadth of expertise in digital health transformation, cybersecurity, artificial intelligence, public policy, workforce development, governance, and analytics to empower healthcare leaders, clinicians, and technology partners across the global health ecosystem.
HIMSS provides critical insights, digital maturity assessment tools, advisory services, educational resources, professional development certifications, and networking opportunities to the global health and technology communities. Learn more at www.himss.org.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Meyers Manx and Tuthill Debut the LFG at The Quail, A Motorsports Gathering
A new era in luxury off-road adventure, launching with six years of curated global driving experiences MONTEREY, Calif., Aug. 15, 2025 /PRNewswire/ -- At the prestigious The Quail, A Motorsports Gathering during Monterey Car Week, Meyers Manx, the legendary creator of the original fiberglass dune buggy, and world-renowned rally specialists Tuthill unveiled the LFG, a limited-production off-road performance machine set to redefine the spirit of recreational driving. Only 100 examples of the LFG will be built, each offering owners exclusive access to six years of meticulously planned driving adventures across the globe. The journey begins in 2027 with the inaugural LFG Baja Tour, marking the 50th anniversary of Meyers Manx's historic victory in the first Mexican 1000 (now the Baja 1000). Designed for those who crave both comfort and capability, the LFG merges cutting-edge engineering with a playful, adventurous spirit. Underneath its carbon fiber body and ROPS (Roll Over Protection Structure) lies a choice of high-performance engines — including a 4-valve variant derived from Tuthill's celebrated "K" — paired with a six-speed sequential gearbox and 4WD featuring front, center, and rear limited-slip differentials. Twin five-way adjustable dampers with hydraulic bump stops, and BF Goodrich All-Terrain tyres ensure the LFG is equally at home crossing desert dunes or carving through rugged mountain trails. Inside, a bespoke, climate-controlled cabin offers comfort on long hauls, while an Inconel exhaust, integrated GPS, and long-range fuel tank prepare the vehicle for journeys well beyond the beaten path. In moments, the enclosed cockpit can transform into an open-air buggy, letting drivers and passengers fully embrace the elements. "This project started as a dream between my long-time pal Richard and me, both in constant pursuit of the ultimate expression of freedom and performance," said Phillip Sarofim, Founder and CEO of Trousdale Ventures and Chairman of the Board at Meyers Manx. "We imagined the perfect Meyers Manx, brought Freeman Thomas on board to infuse his design brilliance, and merged it with Tuthill's engineering mastery. The result is raw, visceral, novel, and totally uncompromising. We call it LFG for a reason." "It's fairly well known that I love experiences, I love the effect it has on those that join us wherever we go," said Richard Tuthill, Director at Tuthill. "This, however, is slightly different. We are not necessarily bringing the stopwatch with us on these trips. I want to take people to see the most amazing parts of the world. I have been super lucky to see some life-changing scenery whilst Rallying, the memories I have as a result are immeasurable. These things change you. I think for the better. We crave experiences that we can look back on for the rest of our lives. We now have an amazing car to help us to create these in a unique way. The car looks fun, mischievous, it has a character that I have genuinely never seen or felt. BUT underneath it's PROPER – could we go to the moon and back in it? Probably yes, it has the capability to go wherever we point it, and we can do it safely and comfortably. In 2 minutes, it transforms from a fully air-conditioned enclosed cabin to a doorless buggy where the wind provides the air that helps us smile. It's very special. I can't wait to get started, please join in – LFG." More details, images, and specifications are available online. About Meyers ManxFounded in 1964 by Bruce Meyers, Meyers Manx is the creator of the original fiberglass dune buggy — an enduring symbol of freedom, adventure, and off-road performance. The brand blends innovation with heritage, inspiring generations of adventurers worldwide. Today, Meyers Manx continues to pioneer the future of recreational and off-road vehicles through a fusion of timeless design and modern engineering. Press Contactinfo@ About TuthillTuthill is a family-owned business based in Oxfordshire, UK, with over 50 years of success in rallying and racing. Known for building high-performance vehicles for both tarmac and off-road terrain, the company's legacy began with Francis Tuthill's participation in the 1977 London to Sydney Marathon. Now under second-generation leadership, Tuthill continues to deliver reliability, competitiveness, and desirability through motorsport and road car programs, including the acclaimed Tuthill K and GT ONE. Press ContactSales Inquiries: David Cox & Richard Tuthill — lfg@ | +44 (0) 1295 750 514Brand & Partnerships: Pia Jarak — pia@ Media Inquiries: Laura Harris — media@ View original content to download multimedia: SOURCE Meyers Manx Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
InventHelp Inventor Develops New Potty Training Accessory (SGM-538)
PITTSBURGH, Aug. 15, 2025 /PRNewswire/ -- "I wanted to create a product that would make potty training a less stressful and more positive experience for parents and children," said an inventor, from New Palestine, Ind., "so I invented THE POTTY PARTNER. My design could help provide a positive transition from diapers to toilet use, and it could allow for successful training in a shorter time or at an earlier age." The patent-pending invention provides an effective accessory for toilet training a child. In doing so, it would teach young children how to use the toilet in a positive and non-stressful manner. It also could help with safety issues. As a result, it could help simplify the task of toilet training. The invention features a durable and novel design that is easy to attach, use, and clean so it is ideal for parents with infants and children ages 3 and younger. Additionally, a prototype model and technical drawings are available upon request. The original design was submitted to the Indianapolis sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-SGM-538, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at View original content to download multimedia: SOURCE InventHelp Sign in to access your portfolio
Yahoo
7 hours ago
- Yahoo
Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR
DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The global Epigenetics Market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of US$4.29 billion by the end of the period. The major factors driving the growth in the flow cytometry market include advancements in technology, increasing adoption of flow cytometry products in clinical diagnostics, rising prevalence of chronic diseases, growing biopharmaceutical R&D, and the need for precision medicine. The significant rise in oncology research has increased the demand for flow cytometry products and services. Additionally, the integration of AI and machine learning is enhancing data analysis capabilities, further fueling market growth. Download PDF Brochure: Browse in-depth TOC on "Epigenetics Market" 365 - Tables45 - Figures353 - Pages By offering, the global epigenetics market is segmented into various categories, including kits and reagents, enzymes, instruments and accessories, software, and services. Within the kits and reagents category, there are sub-segments such as antibodies, chip-sequencing kits and reagents, bisulfite conversion kits and reagents, whole-genome amplification kits and reagents, 5-HMC and 5-MC analysis kits and reagents, histones, as well as other kits and reagents. In 2024, the Antibodies segment is projected to command the largest market share. This is attributed to the increasing reliance on antibodies for the detection, identification, and modification of proteins, along with their essential function in monitoring cellular regulation and gene expression. Consequently, the growth of the antibodies segment is expected to accelerate throughout the forecast period due to these advancements. By Method, the epigenetics market segmentation by methodology includes DNA methylation, histone modifications, and additional approaches such as non-coding RNA interactions and chromatin remodeling. The DNA methylation segment is projected to exhibit a robust compound annual growth rate (CAGR) throughout the forecast period, primarily driven by its proven effectiveness in oncology research applications. By geography, The Asia Pacific region is projected to experience the most rapid growth within the epigenetics market. This expansion is driven by the increasing global footprint of local companies through strategic alliances and collaborations, alongside continuous enhancements in healthcare infrastructure in emerging economies. Moreover, there is a heightened emphasis on advancing capabilities in Next-Generation Sequencing (NGS), which is further propelling market development in the region. Request Sample Pages : Key players in the epigenetics market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Danaher (US), Active Motif, Inc. (US), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Revvity (US), QIAGEN (Germany), among others. Illumina Inc (US): In 2024, Illumina, Inc. maintained a preeminent position in the genomics market, capitalizing on a well-established customer base that includes leading pharmaceutical and biotechnology companies, genomic research institutions, and various government laboratories and hospitals. The firm possesses a dominant market share in the next-generation sequencing (NGS) domain, which affords it a competitive edge when exploring adjacent sectors, such as epigenetic sequencing. A notable move in this direction occurred in June 2025, when Illumina announced its acquisition of SomaLogic. This strategic acquisition is poised to bolster Illumina's footprint in the burgeoning epigenetics market and further its multiomics strategy, integrating diverse biological data for enhanced insights into genomics, transcriptomics, proteomics, and epigenomics. Thermofisher Scientific Inc. (US) Thermo Fisher Scientific Inc. (US) stands out as a prominent player in the epigenetics market in 2024, driven by a robust and diversified product portfolio, an extensive global footprint, and a strategic focus on both organic and inorganic growth initiatives. Notably, in July 2025, the company secured US Food and Drug Administration (FDA) approval for the Oncomine Dx Express Test, utilizing the Ion Torrent Genexus Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay designed for companion diagnostics (CDx) in tumor profiling applications. Thermo Fisher demonstrates a strong commitment to research and development, channeling significant resources into innovation to address the dynamic needs of its clientele. Their comprehensive global distribution network enhances accessibility and customer support, facilitating the delivery of advanced and reliable epigenetics solutions. This multifaceted strategic approach solidifies Thermo Fisher's position as a leading provider in the epigenetics landscape. For more information, Inquire Now! Related Reports: Research Antibodies & Reagents Market Genomics Market Next Generation Sequencing Market PCR Technologies Market Digital PCR and qPCR Market Get access to the latest updates on Epigenetics Companies and Epigenetics Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
